Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction-Reference-Cited by-同舟云学术

Optimising treatments for sexually transmitted infections: surveillance, pharmacokinetics and pharmacodynamics, therapeutic strategies, and molecular resistance prediction

Published:2020-08 Issue:8 Volume:20 Page:e181-e191
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Seña Arlene C,Bachmann Laura,Johnston Christine,Wi Teodora,Workowski Kimberly,Hook Edward W,Hocking Jane S,Drusano George,Unemo Magnus

Publisher

Elsevier BV

Subject

Infectious Diseases

Reference80 articles.

1. World Health Organization Global Gonococcal Antimicrobial Surveillance Program (WHO GASP): review of new data and evidence to inform international collaborative actions and research efforts;Unemo;Sex Health,2019

2. Antimicrobial resistance in Neisseria gonorrhoeae: global surveillance and a call for international collaborative action;Wi;PLoS Med,2017

3. Failure of dual antimicrobial therapy in treatment of gonorrhoea;Fifer;N Engl J Med,2016

4. New horizons in Mycoplasma genitalium treatment;Bradshaw;J Infect Dis,2017

5. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis-infected women with clinical treatment failure;Bosserman;Sex Transm Dis,2011

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment ‘cultures’, sexually transmitted infections and the rise of antimicrobial resistance;Sociology of Health & Illness;2024-09-02

2. US Food and Drug Administration, Centers for Disease Control and Prevention, and National Institutes of Health Co-Sponsored Public Workshop Summary—Development Considerations of Antimicrobial Drugs for the Treatment of Gonorrhea;Clinical Infectious Diseases;2024-07-24

3. Antimicrobial treatment and resistance in sexually transmitted bacterial infections;Nature Reviews Microbiology;2024-03-20

4. Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125–1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea;Journal of Antimicrobial Chemotherapy;2024-03-18

5. Treatment Rates for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) in a Metropolitan Area: Observational Cohort Analysis;Sexually Transmitted Diseases;2024-01-24